Indications

The first and only medicine of its kind​ in MDS-related anemia

Early treatment for anemia is an important part of managing myelodysplastic syndromes (MDS).

A Photo of a hypothetical patient in a plaid shirt holding a painting palette and painting with a loved one holding his paint brush

REBLOZYL is for people with lower-risk MDS-related anemia.

FIRST-LINE TREATMENT

Starting with REBLOZYL as your first medicine

REBLOZYL is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk MDS who may require regular red blood cell (RBC) transfusions.

SECOND-LINE TREATMENT

Switching to REBLOZYL for your next medicine

REBLOZYL is a prescription medicine used to treat anemia (low RBCs) in adults with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).

REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.

It is not known if REBLOZYL is safe or effective in children.

Red blood cells

REBLOZYL is called an erythroid maturation agent (EMA)

An EMA helps immature RBCs (called erythroid cells) develop and become mature, working RBCs. This may result in more healthy RBCs and improved anemia.

How does REBLOZYL work?

Before starting REBLOZYL for MDS-related anemia, it’s important that you learn about how REBLOZYL works. It can also make you feel more confident when talking with your healthcare team.

Watch this short video to see how REBLOZYL works.

Watch how REBLOZYL works video
"One of the nicest things about Reblozyl is that I would be able to go 3 weeks between injections. Stated by Teri, a real Reblozyl Patient. Individual results may vary.

Hear from someone who has managed MDS-related anemia with REBLOZYL.

Logo: Your REBLOZYL® (luspatercept-aamt) Connection™

We have resources for you along every step of your treatment journey

Your REBLOZYL Connection™ is an educational program designed to help you understand treatment with REBLOZYL and provide resources so you can take a more active role in your care.

Ready to ask about REBLOZYL?

When it comes to your managing your MDS-related anemia, you and your care team are in it together. Keeping open lines of communication can help your doctor determine the right treatment plan for you.

Remember: you and your caregiver(s) are your best advocates, and it all starts with asking the right questions.

Select each option below (+) to find answers for some of the most commonly-asked questions:

Doctor Discussion Guide

Get the conversation started with our  Doctor Discussion Guide

Download our complete Doctor Discussion Guide for more information about navigating conversations with your care team. The guide also includes worksheets and places to take notes to help you get organized.



swoosh

This website is intended for U.S. residents 18 years of age or older.

REBLOZYL® is a trademark of Celgene Corporation, a Bristol Myers Squibb company.

Access Support® and Your REBLOZYL Connection are trademarks of Bristol-Myers Squibb Company.

REBLOZYL® is licensed from Merck & Co. Inc., Rahway, NJ, USA and its affiliates.

© 2024 Bristol-Myers Squibb Company.

2007-US-2400432  11/24